Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E
- PMID: 12883485
- DOI: 10.1053/jhep.2003.50316
Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E
Abstract
There are few data evaluating plasma and/or peripheral blood monocyte cytokine concentrations/production or attempts to manipulate proinflammatory cytokines in nonalcoholic steatohepatitis (NASH). A pilot project in a general clinical research center evaluated the effects of a step 1 American Heart Association diet plus aerobic exercise with or without 800 IU of vitamin E daily on cytokine profiles and liver enzyme levels in 16 patients with biopsy-proven NASH. Biochemical assessment of liver function, lipid profiles, and body mass index significantly improved during the first 6 weeks of therapy and remained stable during the following 6 weeks. Plasma hyaluronic acid (HA) concentrations decreased in parallel with weight loss. Plasma tumor necrosis factor (TNF) concentrations were significantly elevated in patients with NASH and similar to patients with stable alcoholic cirrhosis but not as elevated as in patients with acute alcoholic steatohepatitis (AH). Although plasma TNF, interleukin 8 (IL-8), and IL-6 concentrations were all significantly elevated compared with control values, only plasma IL-6 levels significantly decreased with therapy. Peripheral blood monocyte TNF, IL-8, and IL-6 production was significantly elevated in patients with NASH but did not significantly decrease. Independent effects of vitamin E were not observed in this small sample. In conclusion, patients with NASH have dysregulated cytokine metabolism similar to, but less pronounced than abnormalities documented in AH. Cytokine values generally did not decrease significantly with weight loss with or without vitamin E over the duration of the study. Lifestyle modifications (low-fat diet and exercise) were associated with improvement in liver enzymes, cholesterol, and plasma HA levels in patients with NASH, whereas the level of vitamin E supplementation used in this short-term pilot study provided no apparent added benefit.
Comment in
-
Vitamin E therapy in patients with NASH.Hepatology. 2004 Feb;39(2):568; author reply 569-70. doi: 10.1002/hep.20042. Hepatology. 2004. PMID: 14768013 No abstract available.
-
More on vitamin E therapy.Hepatology. 2004 Feb;39(2):569; author reply 569-70. doi: 10.1002/hep.20036. Hepatology. 2004. PMID: 14768015 No abstract available.
Similar articles
-
Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis.Scand J Gastroenterol. 2007 Sep;42(9):1095-101. doi: 10.1080/00365520701286680. Scand J Gastroenterol. 2007. PMID: 17710676
-
Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis.Hepatogastroenterology. 2005 Sep-Oct;52(65):1549-53. Hepatogastroenterology. 2005. PMID: 16201116
-
Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.Alcohol Clin Exp Res. 2000 Apr;24(4 Suppl):48S-54S. Alcohol Clin Exp Res. 2000. PMID: 10803780
-
Non-alcoholic steatohepatitis in children.Pediatr Transplant. 2004 Dec;8(6):613-8. doi: 10.1111/j.1399-3046.2004.00241.x. Pediatr Transplant. 2004. PMID: 15598336 Review.
-
[Non-alcoholic steatohepatitis].Rev Gastroenterol Mex. 2002 Apr-Jun;67(2):118-25. Rev Gastroenterol Mex. 2002. PMID: 12214335 Review. Spanish.
Cited by
-
Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease.Indian J Clin Biochem. 2011 Apr;26(2):202-9. doi: 10.1007/s12291-011-0121-7. Epub 2011 Apr 7. Indian J Clin Biochem. 2011. PMID: 22468051 Free PMC article.
-
The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial.Adv Exp Med Biol. 2021;1308:25-35. doi: 10.1007/978-3-030-64872-5_3. Adv Exp Med Biol. 2021. PMID: 33861434 Clinical Trial.
-
High-salt in addition to high-fat diet may enhance inflammation and fibrosis in liver steatosis induced by oxidative stress and dyslipidemia in mice.Lipids Health Dis. 2015 Feb 13;14:6. doi: 10.1186/s12944-015-0002-9. Lipids Health Dis. 2015. PMID: 25888871 Free PMC article.
-
Qingrequzhuo capsule alleviated methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice through regulating gut microbiota, enhancing gut tight junction and inhibiting the activation of TLR4/NF-κB signaling pathway.Front Endocrinol (Lausanne). 2023 Jan 19;13:1106875. doi: 10.3389/fendo.2022.1106875. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36743916 Free PMC article.
-
New treatments for nonalcoholic fatty liver disease.Curr Gastroenterol Rep. 2006 Feb;8(1):21-9. doi: 10.1007/s11894-006-0060-2. Curr Gastroenterol Rep. 2006. PMID: 16510031 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical